Brought to you by 
Cellomics, J&J to develop drug discovery tools
Jun 1998
Executive Summary
Cellomics (formerly BioDx; cell-based screening) allied with J&J's RW Johnson Pharmaceutical Research Institute to develop new high content drug discovery tools using Cellomics' ArrayScan system.
Deal Industry
-
Biotechnology
-
Drug Discovery Tools
- Molecular Diversity
-
Drug Discovery Tools
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
Deal Status
- Final
Deal Type
-
Alliance
- R+D and Marketing-Licensing
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cellomics, J&J to develop drug discovery tools
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice